South Korea Nebulizer Market Share, Size, Trends, Forecast: By Product Type: Jet Nebulizer, Mesh Nebulizer, Ultrasonic Nebulizer, Others; By Portability: Portable, Standalone; By Application: COPD, Cystic Fibrosis, Asthma, Others; By End User: Hospitals And Clinics, Emergency Centers, Home Healthcare, Others; Competitive Landscape; 2023-2028

South Korea Nebulizer Market Outlook

The South Korea Nebulizer Market size reached a value of more than USD 18.42 million in 2022. The South Korea Nebulizer industry is expected to grow at a CAGR of 5.4% between 2023 and 2028. The life expectancy in Korea is among the highest. This is due to reasonably good medical advancements, easy access to hospitals, and a well-established health insurance system. 

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Trends in the South Korea Nebulizer Market

A medical gadget called a nebulizer turns medication into a mist and then delivers it right to the lungs. Nebulization is done with a variety of equipment. Nebulization is a frequent therapy method for respiratory conditions such as asthma, cystic fibrosis, and COPD. The most popular devices are electrically powered and rechargeable. 

Increasing Respiratory Diseases Among People and Technological Developments to Bolster the Nebulizer Market in South Korea

Nebulizer is put into use when someone struggles to breathe and needs a dose of medicine to relieve it. These days due to the increased respiratory ailments among people of all ages, the industry of Nebulizers is booming in the country. It can also be easily used for babies and young kids. Inflammation and persistent airway infection in cystic fibrosis are successfully treated with topical aerosolized treatments (CF). Recent advancements in nebulizer technology have made it possible to deliver mesh-generated aerosol particles via adaptive aerosol delivery (AAD), which results in more effective airway deposition than current jet nebulizers. These modern gadgets also have the capacity to download previously stored data in order to record and analyse the device's performance (electronic data capture). 

Furthermore, companies that produce respiratory devices are increasingly investing in portable and simple-to-use nebulizers to administer medications quickly and effectively while cutting down on treatment time. Easy-to-use nebulizers that have rechargeable batteries integrated into are already being produced.

The Rise in Ageing Population and Lifestyle Changes Increases the Demand for Nebulizer in South Korea

The demand for nebulizers is increasing as a result of an ageing population and an increase in the prevalence of various respiratory disorders. Around 65 million people worldwide have COPD, and 3 million people worldwide pass away from it each year, according to the World Health Organization. South Korea is edging closer to post-pandemic living after combating the novel coronavirus, with the withdrawal of practically all social distancing measures. These days the primary causes of the rise in respiratory issues include changing lifestyles, rising pollution levels, and rising smoking rates. With the improved standard of living and high purchasing power, people now can afford their personal nebulizers to use at home.

Market Analysis

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on product type, the South Korea Nebulizer market is segmented into jet Nebulizer, mesh Nebulizer, and ultrasonic Nebulizer, among others. On the basis of portability, the Nebulizer market of South Korea is divided into portable and standalone. Based on application, the South Korea Nebulizer Market is bifurcated into COPD, cystic fibrosis, and asthma, among others. On the basis of end user, the Nebulizer market of South Korea is classified into hospitals and clinics, emergency centres, and home healthcare, among others.

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the South Korea Nebulizer Market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans. 

• Omron Corporation

• GE HealthCare

• M.I. ONE Co. Limited

• Medstar Co., Ltd

• KTMED INC.

• Boditech Med Inc

• Others

Market Share by Product Type

To create an aerosol, a jet nebulizer employs compressed gas (tiny particles of medicine in the air). Through high-frequency vibrations, an aerosol is created by an ultrasonic nebulizer. When using a jet nebulizer, the particles are bigger. To create the aerosol, liquid flows through a very thin mesh in a mesh nebulizer. The tiniest particles are released by this type of nebulizer. Additionally, it is the costliest. During the projection period, the mesh is anticipated to be the section with the most opportunity. Mesh nebulizer demand is increasing globally because of the new innovations and technology employed in them. These nebulizers' introduction of cutting-edge technology is accelerating the growth of the market.

Market Share by Portability

standalone nebulizers are intended for use at home and should be positioned on a stable surface. They require an electrical connection to function. The biggest disadvantage of standalone nebulizers is that the patient remains immobile while receiving treatment. On the other hand, for those who lead a hectic lifestyle and are not constantly at home for nebulizer treatments, portable nebulizers are a great option. Portable nebulizers, which are typically smaller than a deck of cards and run on batteries, allow patients to take their pulmonary medications wherever they go. Although there are versions to suit most budgets.

Market Share by Application

Because it distributes antibiotics directly to the endobronchial site of infection and is linked with lower toxicity due to the restricted systemic absorption, nebulization is a beneficial delivery strategy in cystic fibrosis (CF). People with other respiratory conditions, such as COPD, who experience lung-related symptoms from a cold or the flu may also benefit from nebulizer treatments. A nebulizer may be used by many COPD patients to assist deliver medicine deep into the lungs, where it is most required. Nebulizer therapy, particularly in the case of respiratory disorders like asthma, may aid in reducing inflammation of the lungs or open airways. Therefore, all three ailments require the use of a Nebulizer for effective management, thereby proliferating the growth of the Nebulizer industry in South Korea.

Market Share by End User

The standard method of administering bronchodilators to elderly patients and hospitalised patients is the small-volume jet nebulizer, which is widely used. These gadgets are affordable and don't need much help from the patient. They are also helpful for administering drugs with a substantial mass, including antibiotics. Hospital doctors switched from employing jet nebulizers to MDIs with spacers during the COVID-19 respiratory virus pandemic of 2020 out of worry about the exposure of healthcare workers to possibly infected aerosols during the nebulization of bronchodilators. With the surge of respiratory diseases, the use of Nebulizers has increased drastically among all the mentioned end users.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape

GE HealthCare- A leading producer of medical devices, GE HealthCare Technologies Inc (GE HealthCare) creates, develops, produces, and sells diagnostic imaging and clinical systems, as well as goods and services for the development of new drugs, the production of biopharmaceuticals, and cellular technologies, among others. the headquarter of GE Healthcare is situated in Chicago, U.S.A. and was incorporated in the year 1994.  

Boditech Med Inc.- Pharmaceutical firm Boditech Med Inc offers diagnostic services. It creates, produces, and distributes in-vitro diagnostics and diagnostic reagent products. The business is also creating a smart manufacturing system that combines IT and digital technology. The company creates its medicines to treat conditions including arthritis, diabetes, hormones, cancer, and heart disease. The head office of Boditech Med Inc. is in Chuncheon, South Korea.

Key Highlights of the Report

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.